← Open Payments lookup

KAYLA CRAWFORD: Open Payments

NPI 1073168837 · DRASCO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$627 in 39 payments from 12 companies in 2025. Trend: 2023 $361 · 2024 $570 · 2025 $627

Food & beverage: $627
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.8$185
ABBVIE INC.16$158
AstraZeneca Pharmaceuticals LP2$57
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$54
GlaxoSmithKline, LLC.2$34
Lilly USA, LLC2$31
E.R. Squibb & Sons, L.L.C.1$25
Novo Nordisk Inc1$23
Lundbeck LLC1$18
Verona Pharma, Inc.1$16

Products named: REXULTI, VRAYLAR, BREZTRI, CAPLYTA, TRELEGY ELLIPTA, MOUNJARO, COBENFY, Ozempic.

Industry payments across AR — which companies pay providers there.